Quince Therapeutics, Inc. (IRLA) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Oct 6Oct 9Oct 14Oct 19Oct 22Oct 27Oct 30Nov 4

Key dataNov 4, 2026

Open$33.80

From 52W high−96.40%

Volume57895.00

Market cap$32.21M

P/E (TTM)—

P/S (TTM)—

Div yield—

Key dataNov 4, 2026

Open

$33.80

From 52W high

−96.40%

Volume

57895.00

Market cap

$32.21M

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−0.8x

P/E (TTM)

—

RSI (14)

51.6

MomentumView details →

1D Return

−4.49%

YTD Return

−95.12%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

−0.8x

EV/Sales

—

P/S (TTM)

—

P/B (TTM)

0.3x

ProfitabilityView details →

Gross Margin

—

Net Margin

—

EBITDA Margin

—

ROE (TTM)

−85.24%

ROA (TTM)

−74.58%

Asset Turnover

0.00x

GrowthView details →

Revenue YoY

—

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

—

EPS CAGR 3Y

−28.24%

EBITDA YoY

—

MomentumView details →

1D Return

−4.49%

YTD Return

−95.12%

1Y Return

−89.66%

RSI (14)

51.6

vs 50D SMA

+5.08%

vs 200D SMA

−27.57%

Capital & dividendView details →

Debt/Equity

0.00x

Current Ratio

14.52x

Quick Ratio

14.52x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

−$1.45

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

0.00

Net Income (TTM)

−92.48M

Op. CF (TTM)

−46.92M

Next earningsNov 11, 2026 →

Latest newsMore news →

No recent news for IRLA.

Similar companies

Quince Therapeutics, Inc.QNCX Leap Therapeutics, Inc.LPTX Lite Strategy, Inc.LITS Aligos Therapeutics, Inc.ALGS EyePoint Pharmaceuticals, Inc.EYPT Elutia Inc.ELUT Find similar companies →

Latest newsMore news →

No recent news for IRLA.